Die Arbeit analysiert anhand eines Fallbeispiels die finanziellen Fragen rund um die mögliche Markteinführung eines fiktiven pharmazeutischen Produktes.
Folgende Aspekte werden ausgeführt bzw. berechnet:
- Break even
- EBITDA / „Gewinn vor Zinsen, Steuern, Abschreibungen (auf Sachanlagen) und Abschreibungen (auf immaterielle Vermögensgegenstände)“
- Cash Flow / Geldfluss
- Internal Rate of Return / Interner Zinsfuß
- Net Present Value / Kapitalwert
- Investment Payback Period / Amortisationsdauer
- Sensitivitätsanalyse
Die Analyse erfolgt in Form eines fiktiven Berichts für die Leitung des Fallunternehmens.
Inhaltsverzeichnis (Table of Contents)
- Introduction
- Financial Analysis Citronex
- Profitability
- Capital Investment
- Financial risk assessment
- Additional Risk Considerations
- Theoretical Framework
- Conclusion
- Appendix
- Appendix A: Basic Information Repulse Travel Pharmaceuticals
- Appendix A1: Company Information
- Appendix A2: Citronex Product Information
- Appendix A3: Financial Data for "Citronex"
- Appendix A: Basic Information Repulse Travel Pharmaceuticals
- References
Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)
This report aims to provide a thorough analysis of the financial feasibility and profitability of introducing a new product, "Citronex," developed by Repulse Travel Pharmaceuticals (RTP), to the market. The report will analyze sales, cost, and investment data to create a recommendation for the introduction of Citronex to the RTP board. The key themes explored in this analysis include:- Profitability analysis of Citronex
- Capital investment assessment for Citronex
- Financial risk assessment and mitigation strategies
- Evaluation of additional investment considerations
- Sensitivity analysis of key financial parameters
Zusammenfassung der Kapitel (Chapter Summaries)
The introduction provides a brief overview of the report's purpose and scope, setting the stage for the comprehensive financial analysis of Citronex. The "Financial Analysis Citronex" section delves into a thorough examination of Citronex's profitability, capital investment requirements, and associated financial risks. This section also considers additional risk factors that could impact the investment decision. The "Theoretical Framework" section explores the underpinnings of the financial analysis methodologies used in the report, providing context for the employed techniques. The conclusion summarizes the major findings and recommendations for the introduction of Citronex, based on the comprehensive financial analysis presented.
Schlüsselwörter (Keywords)
This report focuses on the application of corporate finance principles and techniques to assess the financial feasibility of introducing a new pharmaceutical product. Key keywords include: investment appraisal, financial analysis, financial ratios, profitability, capital investment, risk assessment, sensitivity analysis, and discounted cash flow.- Quote paper
- Florian C. Kleemann (Author), 2010, Investment Appraisal and Financial Analysis, Munich, GRIN Verlag, https://www.grin.com/document/190094
